Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial
Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial
BACKGROUND: A shift towards parenchymal-sparing liver resections in open and laparoscopic surgery emerged in the last few years. Laparoscopic liver resection is technically feasible and safe, and consensus guidelines acknowledge the laparoscopic approach in the posterosuperior segments. Lesions situated in these segments are considered the most challenging for the laparoscopic approach. The aim of this trial is to compare the postoperative time to functional recovery, complications, oncological safety, quality of life, survival and costs after laparoscopic versus open parenchymal-sparing liver resections in the posterosuperior liver segments within an enhanced recovery setting.
METHODS: The ORANGE Segments trial is an international multicentre randomised controlled superiority trial conducted in centres experienced in laparoscopic liver resection. Eligible patients for minor resections in the posterosuperior segments will be randomised in a 1:1 ratio to undergo laparoscopic or open resections in an enhanced recovery setting. Patients and ward personnel are blinded to the treatment allocation until postoperative day 4 using a large abdominal dressing. The primary endpoint is time to functional recovery. Secondary endpoints include intraoperative outcomes, length of stay, resection margin, postoperative complications, 90-day mortality, time to adjuvant chemotherapy initiation, quality of life and overall survival. Laparoscopic liver surgery of the posterosuperior segments is hypothesised to reduce time to functional recovery by 2 days in comparison with open surgery. With a power of 80% and alpha of 0.04 to adjust for interim analysis halfway the trial, a total of 250 patients are required to be randomised.
DISCUSSION: The ORANGE Segments trial is the first multicentre international randomised controlled study to compare short- and long-term surgical and oncological outcomes of laparoscopic and open resections in the posterosuperior segments within an enhanced recovery programme.
TRIAL REGISTRATION: ClinicalTrials.gov NCT03270917 . Registered on September 1, 2017. Before start of inclusion.
PROTOCOL VERSION: version 12, May 9, 2017.
Hepatectomy/adverse effects, Humans, Laparoscopy/adverse effects, Length of Stay, Liver Neoplasms/surgery, Multicenter Studies as Topic, Quality of Life, Randomized Controlled Trials as Topic, Treatment Outcome
206
Kuemmerli, Christoph
85b9f630-6845-4b8a-bbd7-76ace58cebfb
Fichtinger, Robert S
055adb24-2b61-43e7-b4f5-a934d573aedb
Moekotte, Alma
c872a6c9-c212-4ddf-9870-6fb191c8ec06
Aldrighetti, Luca A
a4b19d20-4a6e-4b98-9267-f76edcd689a0
Aroori, Somaiah
842a95b8-42fb-462d-85a7-faeefd6ecea0
Besselink, Marc G H
4c2d9780-7d9c-4571-8e0e-f8df543b14aa
D'Hondt, Mathieu
dad5077e-c50f-45dc-a433-f5e327566bb6
Díaz-Nieto, Rafael
d2ca8448-b3ea-4fe9-b432-2e23e3f160c3
Edwin, Bjørn
b04994d3-928a-49ad-8bdf-183c7e7a08d2
Efanov, Mikhail
ceefe17f-20c9-4add-837c-0d9a3edca254
Ettorre, Giuseppe M
cc13268d-f8dd-4fa1-991d-2227fe23805d
Menon, Krishna V
d07aeb0b-4e37-4f9a-b23c-55d5d35fa535
Sheen, Aali J
345305f5-07e3-450b-84be-206a1bcc98c6
Soonawalla, Zahir
ecf14061-123f-4afe-9a01-1c65b0ac6444
Sutcliffe, Robert
53a0327d-e30f-4bf9-a284-986a82268276
Troisi, Roberto I
13220f60-fb66-44c5-b957-0f9a5936b0c7
White, Steven A
11ad3254-7def-4d57-8a74-12e8312d37f2
Brandts, Lloyd
b4e4d995-9b05-4659-ba6f-aaae93adc1d4
van Breukelen, Gerard J P
8379c2c7-5462-4b8e-8195-178bb03ce6e9
Sijberden, Jasper
a3423af5-8758-413a-b913-eead6095f8b8
Pugh, Siân A
e0d0bdb3-f772-48b2-84bd-fb25045bef94
Eminton, Zina
44904d98-97be-4080-9a84-bf5742525f8e
Primrose, John N
d85f3b28-24c6-475f-955b-ec457a3f9185
van Dam, Ronald
7523218d-f43b-4c5c-9117-b4e22649eab3
Hilal, Mohammed Abu
69c1c58b-e5bd-4896-8729-a6780f6b3105
ORANGE trials collaborative
9 March 2022
Kuemmerli, Christoph
85b9f630-6845-4b8a-bbd7-76ace58cebfb
Fichtinger, Robert S
055adb24-2b61-43e7-b4f5-a934d573aedb
Moekotte, Alma
c872a6c9-c212-4ddf-9870-6fb191c8ec06
Aldrighetti, Luca A
a4b19d20-4a6e-4b98-9267-f76edcd689a0
Aroori, Somaiah
842a95b8-42fb-462d-85a7-faeefd6ecea0
Besselink, Marc G H
4c2d9780-7d9c-4571-8e0e-f8df543b14aa
D'Hondt, Mathieu
dad5077e-c50f-45dc-a433-f5e327566bb6
Díaz-Nieto, Rafael
d2ca8448-b3ea-4fe9-b432-2e23e3f160c3
Edwin, Bjørn
b04994d3-928a-49ad-8bdf-183c7e7a08d2
Efanov, Mikhail
ceefe17f-20c9-4add-837c-0d9a3edca254
Ettorre, Giuseppe M
cc13268d-f8dd-4fa1-991d-2227fe23805d
Menon, Krishna V
d07aeb0b-4e37-4f9a-b23c-55d5d35fa535
Sheen, Aali J
345305f5-07e3-450b-84be-206a1bcc98c6
Soonawalla, Zahir
ecf14061-123f-4afe-9a01-1c65b0ac6444
Sutcliffe, Robert
53a0327d-e30f-4bf9-a284-986a82268276
Troisi, Roberto I
13220f60-fb66-44c5-b957-0f9a5936b0c7
White, Steven A
11ad3254-7def-4d57-8a74-12e8312d37f2
Brandts, Lloyd
b4e4d995-9b05-4659-ba6f-aaae93adc1d4
van Breukelen, Gerard J P
8379c2c7-5462-4b8e-8195-178bb03ce6e9
Sijberden, Jasper
a3423af5-8758-413a-b913-eead6095f8b8
Pugh, Siân A
e0d0bdb3-f772-48b2-84bd-fb25045bef94
Eminton, Zina
44904d98-97be-4080-9a84-bf5742525f8e
Primrose, John N
d85f3b28-24c6-475f-955b-ec457a3f9185
van Dam, Ronald
7523218d-f43b-4c5c-9117-b4e22649eab3
Hilal, Mohammed Abu
69c1c58b-e5bd-4896-8729-a6780f6b3105